Home » Newsletters » BioWorld Science

BioWorld Science

April 30, 2001

View Archived Issues

Patient recruitment complete in Cangene's three phase III trials

Ophidian updates merger plan with Hemoxymed

SkyePharma summarizes major achievements over past year

NeoTherapeutics receives U.S. patent for technology with broad therapeutic applications

Vertex reports Q1 2001 results

Antiparkinsonian A-7 blocks open NMDA channels similar to adamantane

PhotoCure seeks marketing approval for Metvix(R) PDT in New Zealand

GlaxoSmithKline Biologics and MVI to initiate pediatric clinical trial of malaria vaccine

Aventis prepares oxindoles as potent inhibitors of cyclin-dependent kinases

Vasogen plans trial of immune modulation therapy for PAD

Medarex and Neuro Therapeutics enter alliance to develop antibody therapeutics

ImClone Systems achieves milestone in BEC2 collaboration with Merck KGaA

Scios updates status, reviews progress of lead products

MX-2060: a novel caspase-activating apoptosis inducer discovered at Maxim

Avant Immunotherapeutics reports highlights for the quarter

IntaBiotics' Protegrin IB-367 rinse meets secondary but not primary endpoints

Progenics and Roche extend HIV therapeutics collaboration

3-D Pharmaceuticals and Boehringer Ingelheim extend drug discovery collaboration

Forbes Medi-Tech provides additional preclinical study results for FM-VP4

Organogenesis provides brief product update

Lilly claims new use of parathyroid hormone

Direct delivery of bFGF shown to be useful in wound healing model

New endothelin receptor antagonists useful for circulatory disorders

New compounds interacting with estrogen receptors useful for menopausal disorders, etc.

Aventis presents new NHE-3 inhibitors

New 5-HT6 receptor modulators useful for CNS disorders patented by Pharmacia

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...